2型糖尿病、冠心病患者超敏C-反应蛋白和β_2-微球蛋白测定的临床应用被引量：5

下载PDF

导出

摘要目的探讨2型糖尿病、冠心病患者血清中超敏C-反应蛋白(hs-CRP)和β2-微球蛋白(β2-MG)的水平及其临床应用价值。方法用免疫散射比浊法分别测定糖尿病组(A组)、冠心病组(B组)、健康对照组(C组)血清hs-CRP和β2-ΜG的含量。结果A组、B组患者血清hs-CRP和β2-ΜG均显著高于C组(P(0.01)。结论hs-CRP、β2-ΜG可作为糖尿病、冠心病早期诊断和预后的观察指标。

作者蒋新颖张颖金玉崔续玲

机构地区徐州医学院附属医院检验科

出处《徐州医学院学报》 CAS 2007年第10期649-650,共2页 Acta Academiae Medicinae Xuzhou

关键词超敏C-反应蛋白 Β2-微球蛋白 2型糖尿病冠心病

分类号 R541.4 [医药卫生—心血管疾病] R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献9

1Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis ?[J]. Eur Heart J, 2002, 23 (11) : 831 -834.
2Ross R. Atherosclerosis - - an inflammatory disease [J]. N Engl J Med, 1999, 340(2) : 115 -126.
3Ridker PM, Hennekens CH, Buring rE, et al. C - reactive protein and other maekers of inflammation in the prediction of cardiovascular disease in women [J].N Engl J Med, 2000, 342(3) : 836 - 843.
4Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease [ J ]. JAMA, 2003,290 (7) : 932 - 940.
5李秀芬,许力舒.血清高敏c反应蛋白浓度与冠心病的相关性研究[J].新疆医学,2006,36(3):20-23. 被引量：2
6李国娟,文芳.2型糖尿病患者超敏CRP水平与IMT关系初探[J].实用糖尿病杂志,2006,2(1):35-37. 被引量：11
7Schulze MB, Rimm EB, Li T, et al. C - reactive protein and incident cardiovascular events among men with diabetes [ J]. Diabetes Care, 2004, 27 (4): 889-894.
8温奕欣,洪晓鹏,郑卫军.尿微量蛋白测定在肾脏疾病中的应用价值[J].实用医技杂志,2005,12(03A):570-571. 被引量：5
9熊苏.中老年高血压病和糖尿病早期肾脏损害的检测[J].中华核医学杂志,2000,20(5):210-210.

二级参考文献23

1Padhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2003,23:831.
2Barghouti N, Elkele S, Nicolaides A, et al. The ultrasonic evaluation of the carotid intima- media thickness and its relation to risk factors of atherosclerosis in normal and diabetic population. Int Angioool 1997,16:50.
3Pick JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diahetologia 1998,41:1241.1248.
4Grau AJ. Buggle F, Becher H, et al. The association of leukodyte count, fibririogen and C- reactive protein with vascular risk and ischemic vascular diseases. Thrombosis research 1996,82(3):245 -255.
5Ford ES. Body mass index, diabetes, and C - reactive protein among US adults. Diabetes Care 1999,22:1971 - 1977.
6Devera JS, Jialal I. Alpha tocopherol supplementation decreases serum C- reactive protein and monocyte interleukin - 6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 2000,29:790.
7Kazmierski R, Podsiadly E, Tylewska - Wierzbanowska S, et al.Association between carotid atherosclerosis, inflammatory markers and Chlamydia pneumoniae infec. Neural Neurochir Pol 2005,39 (4) : 277-86.
8Kang ES. Kim HJ. Kim YM, et al. Serum high sensitivity C-reactive protein is associated with carotid intima - media thickness in type 2 diabetas.Diabetes Res Clin Pract 2004,66 Suppl 1 :S115- 20.
9Vilborg S, Bin F, Johannes H. Preclinical Atherosclerosis and Inflammation in 61 - Year - Old Men With Newly Diagnosed Diabetes and Established Diabetes. Diabetes Care 2004, 27(4) : 880 - 4.
10Leinonen ES. Hiukka A, Hurt - Camejo E. et al. Low - grade inflammation, endothelial activation and carotid intima - media thickness in type 2 diabetes, J Intern Med. 2004,256(2) : 119 - 27.